Pathological prognostic factors in the second British Stomach Cancer Group trial of adjuvant therapy in resectable gastric cancer.

The second British Stomach Cancer Group trial was a prospective randomised controlled trial of adjuvant radiotherapy or cytotoxic chemotherapy after gastrectomy for adenocarcinoma. It recruited between 1981 and 1986. No survival advantage has been demonstrated for the patients receiving either type...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, C. C., Levison, D. A., Dunn, J. A., Ward, L. C., Demonakou, M., Allum, W. H., Hallisey, M. T.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1995
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033774/
https://www.ncbi.nlm.nih.gov/pubmed/7734309

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033774/
https://www.ncbi.nlm.nih.gov/pubmed/7734309

Ejemplares similares